These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12). Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254 [TBL] [Abstract][Full Text] [Related]
5. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome. Labeau A; Fery-Simonian L; Lefevre-Utile A; Pourcelot M; Bonnet-Madin L; Soumelis V; Lotteau V; Vidalain PO; Amara A; Meertens L Cell Rep; 2022 Apr; 39(4):110744. PubMed ID: 35477000 [TBL] [Abstract][Full Text] [Related]
6. High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA. Jiang L; Xiao M; Liao QQ; Zheng L; Li C; Liu Y; Yang B; Ren A; Jiang C; Feng XH mSystems; 2023 Aug; 8(4):e0013523. PubMed ID: 37314180 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. Prentice E; McAuliffe J; Lu X; Subbarao K; Denison MR J Virol; 2004 Sep; 78(18):9977-86. PubMed ID: 15331731 [TBL] [Abstract][Full Text] [Related]
8. Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging. Terasaki K; Narayanan K; Makino S J Virol; 2023 Jul; 97(7):e0065923. PubMed ID: 37367225 [TBL] [Abstract][Full Text] [Related]
9. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4). Kaur R; Tada T; Landau NR mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452 [TBL] [Abstract][Full Text] [Related]
10. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery. Royster A; Ren S; Ma Y; Pintado M; Kahng E; Rowan S; Mir S; Mir M Microbiol Spectr; 2023 Jun; 11(3):e0118623. PubMed ID: 37199631 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2: from its discovery to genome structure, transcription, and replication. Brant AC; Tian W; Majerciak V; Yang W; Zheng ZM Cell Biosci; 2021 Jul; 11(1):136. PubMed ID: 34281608 [TBL] [Abstract][Full Text] [Related]
14. Properties of Coronavirus and SARS-CoV-2. Malik YA Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926 [TBL] [Abstract][Full Text] [Related]
15. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins. de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense. Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567 [TBL] [Abstract][Full Text] [Related]
18. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay. Bai X; Sun H; Wu S; Li Y; Wang L; Hong B Front Immunol; 2022; 13():844749. PubMed ID: 35464436 [TBL] [Abstract][Full Text] [Related]
19. Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein - an Amin M; Abbas G J Biomol Struct Dyn; 2021 Aug; 39(12):4243-4255. PubMed ID: 32469265 [TBL] [Abstract][Full Text] [Related]